Authorisation marks major step in European preparedness against ricin
Most U.S. adults have risk factors tied to a little-known condition called CKM syndrome, which connects heart disease, […]
Australia has approved controversial Alzheimer’s drug lecanemab after two rejections.1 The amyloid hypothesis posits that amyloid is the […]
Doctors, scientists, and public health experts have urged the World Health Organization (WHO) to recommend that healthcare workers […]
A bounce back in flu admissions has been seen in NHS hospitals since Christmas as services grapple with […]
Safety warnings for gabapentinoids, benzodiazepines, and non-benzodiazepines (z drugs) are to be strengthened to give doctors and patients […]
Mounjaro: Experts issue warning over black market jabs, with fifth of areas still lacking NHS access
One in five local areas in England still do not provide the weight loss jab tirzepatide (Mounjaro) on […]
Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and […]
Scientists are to compare tumour specimens from the 1950s to those from today to try to identify what […]
